Industrie Pharmaceutique • MA0000011660
Borsalia tracks PROMOPHARM with its price, intraday chart, filings, and company-linked news on the Casablanca Stock Exchange.
By creating high-quality products and making them accessible to those who need them, we are helping to shape a healthier world that enriches all our communities. Based on the latest available figures (2024), the company shows revenue of 898.71M.
PROMOPHARM price, daily move, turnover, and session range are grouped at the top of the page for a quick public-market read.
Liquidity, spread, and turnover to judge tradability.
Peer comparisons with SOTHEMA and Akdital and related listed names.
Company-linked filings, news, and market context around PROMOPHARM.
By creating high-quality products and making them accessible to those who need them, we are helping to shape a healthier world that enriches all our communities.
Direct exposure to the Industrie Pharmaceutique sector.
| Company | Price | 1D change | Market cap | P/E | Liquidity |
|---|---|---|---|---|---|
| 1.350,00 MAD | +0.00% | 1,4 Md MAD | -- | light |
 | 377,00 MAD | -0.53% | 2,9 Md MAD | -- | light |
 |
Promopharm (market) est une société pharmaceutique marocaine majoritairement contrôlée par Hikma (≈94%). CA en hausse sur 2022‑2024 (898,7 M MAD en 2024) mais résultat net en repli (55,16 M MAD en 2024) et ROE en baisse. Capitalisation ~1,35 Md MAD; flottant public très faible (~5,9%) et liquidité de marché limitée. Actualités récentes: communiqué de résultats 2025 publié (31/03/2026); profit warning et annonce d’absence de dividende communiqués en avril 2026. Données détaillées 2025 non entièrement présentes dans le snapshot.
The PROMOPHARM quote is the entry point: last price, change, range, volume, and traded value. Before drawing a quick conclusion, compare that move with liquidity, recent chart behavior, and the role of PRO within Industrie Pharmaceutique. A single move may reflect real information, but it can also come from a thin order book or a session with limited turnover.
Listed filings help explain results, releases, notices, and events that may sit behind a price move. Recent news is a monitoring signal, but the stronger workflow is to open filings, check dates, and compare the content with the page metrics. Events and dividends should be read in the same context.
The displayed shareholder structure adds governance context, but it does not replace fundamentals, valuation, and peer comparison. Use comparable companies, financial indicators, and dividend history to separate a temporarily active stock from a company whose underlying data is changing. Borsalia keeps this page informational: no target price and no personalized recommendation.
For PRO, the strongest reading follows the same order every time: price and volume, chart, filings, events, fundamentals, shareholders, then sector comparison. This routine makes company pages comparable and prevents one visible module from dominating the read. If a tab looks sparse, treat it as a verification signal: it often means a publication is missing, a data field is not exploitable, or a consistency check is still open. Keep the same checklist when comparing peers so the conclusion is based on a repeatable method.
Verified shareholder structure available for this page.
Recent official issuer documents linked to the stock.
Automated news and release monitoring.
| 1.171,00 MAD |
| -0.43% |
| 16,6 Md MAD |
| -- |
| light |
 | 1.220,00 MAD | +0.00% | 1,2 Md MAD | -- | light |
 | 129,30 MAD | -0.54% | 7,8 Md MAD | -- | light |
 | 32,80 MAD | -0.58% | 13,2 Md MAD | -- | light |
